How do you identify key opinion leaders to support your pharmacetical business strategy?
Objectively identifying key opinion leaders (KOLs), scientific experts or clinical investigators can be an onerous task. In a new white paper, we propose a solution for optimal KOL identification and selection.
Pharmaceutical, biotechnology and medical devices companies enlist scientific experts as consultants to conduct basic research, assess the market, design and conduct clinical trials, and drive marketing and educational activities. These experts are often referred to as key opinion leaders (KOLs).
In major therapeutic areas, the top KOLs are known in the industry through their celebrity and tenure. However other leading KOLs, whose scientific influence is apparent by the many times others have cited their work, are either less known or unknown to industry. These experts are the hidden gems in the pharmaceutical KOL mines. This new paper discusses the regulatory aspects of the KOL / industry relationship, proposes a primary means of determining KOL relevance, discusses methods for identifying KOLs to suit your business strategy, and proposes a solution for optimal KOL identification and selection.
Was this article useful?
Download a PDF of all
December 2008's
KnowledgeLink articles
Register now for KnowledgeLink, our customizable email newsletter that delivers expert insight on:
- Global innovation
- Information professional development
- Intellectual property
- Pharmaceutical knowledge
- Scientific research